Insmed, Inc. (NASDAQ:INSM)

CAPS Rating: 4 out of 5

Insmed Incorporated, a biopharmaceutical company, is focused on developing and commercializing novel, targeted inhalation therapies.

Recs

1
Player Avatar solanZRaider (< 20) Submitted: 6/26/2012 4:07:27 PM : Outperform Start Price: $3.18 INSM Score: +281.77

ZZ Top

Report this Post Reply

Featured Broker Partners


Advertisement